Fund Holdings — Samsara BioCapital, LLC

Total Portfolio Value:
$765.93M
Total Bought:
$186.74M
Total Sold:
$36.06M
Net Transaction:
+$150.68M
Notable People:
Michael Philip Dybbs
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Mineralys Therapeutics, Inc.(MLYS)5,674,9166,263,151+588,235$76.78M$237.50M31.01%+$160.72M
Scholar Rock Holding Corporation(SRRK)5,612,8965,612,8960$198.81M$209.02M27.29%+$10.22M
Kalaris Therapeutics, Inc.(KLRS)11,448,08111,448,0810$30.57M$66.17M8.64%+$35.60M
Septerna, Inc.(SEPN)3,149,1283,149,1280$33.29M$59.24M7.73%+$25.95M
Neurogene Inc.(NGNE)1,717,1271,717,1270$25.67M$29.76M3.89%+$4.09M
Alumis Inc4,801,3704,801,3700$14.40M$19.16M2.50%+$4.75M
Upstream Bio, Inc.(UPB)1,443,231962,154-481,077$15.85M$18.10M2.36%+$2.25M
Gossamer Bio, Inc.(GOSS)6,130,2686,130,2680$7.54M$16.12M2.10%+$8.58M
LENZ Therapeutics, Inc.(LENZ)343,012343,0120$10.05M$15.98M2.09%+$5.92M
Aquestive Therapeutics Inc02,500,000+2,500,000$0$13.97M1.82%+$13.97M
Palvella Therapeutics, Inc.(PVLA)339,743209,634-130,109$7.66M$13.14M1.72%+$5.48M
Avadel Pharmaceuticals Plc675,504675,5040$5.98M$10.31M1.35%+$4.34M
vTv Therapeutics Inc.CL A(VTVT)206,784374,461+167,677$3.10M$8.74M1.14%+$5.64M
Nkarta, Inc.(NKTX)3,768,0353,768,0350$6.25M$7.80M1.02%+$1.54M
Contineum Therapeutics, Inc.CL A(CTNM)588,816571,142-17,674$2.34M$6.71M0.88%+$4.37M
Arcellx Inc
COMMON STOCK
101,45781,165-20,292$6.68M$6.66M0.87%-$17.3K
ABIVAX Société AnonymeADS(ABVX)075,442+75,442$0$6.41M0.84%+$6.41M
Jade Biosciences Inc531,163531,1630$5.31M$4.58M0.60%-$722.4K
Aura Biosciences, Inc.(AURA)1,000,000584,849-415,151$6.26M$3.61M0.47%-$2.65M
Zymeworks Inc.(ZYME)310,300207,901-102,399$3.89M$3.55M0.46%-$343.3K
Surrozen, Inc.(SRZN)241,400241,4000$2.16M$3.11M0.41%+$952.3K
Rhythm Pharmaceuticals, Inc.(RYTM)50,47630,285-20,191$3.19M$3.06M0.40%-$131.1K
Sutro Biopharma, Inc.(STRO)2,196,8142,196,8140$1.57M$1.91M0.25%+$339.4K
Terns Pharmaceuticals Inc202,348135,573-66,775$754.8K$1.02M0.13%+$263.4K
Bolt Biotherapeutics Inc52,45648,830-3,626$302.7K$259.8K0.03%-$42.9K
Nuvation Bio Inc.W EXP 02 10 202(NUVB)133,333133,3330$36.0K$26.9K0.00%-$9.0K
Surrozen, Inc.W EXP 08 01 203(SRZN)99,99999,9990$1.8K$1.8K0.00%-$30
Artiva Biotherapeutics, Inc.(ARTV)291,6660-291,666$440.4K$0—-$440.4K
Cargo Therapeutics Inc4,415,6890-4,415,689$18.19M$0—-$18.19M
Hillevax Inc399,6370-399,637$795.3K$0—-$795.3K
Tango Therapeutics, Inc.(TNGX)210,0000-210,000$1.08M$0—-$1.08M
Page 1 of 1
Samsara BioCapital, LLC — 13F Holdings — Q3 2025 | TickerTrail